These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6896172)
1. Immunological disturbances in toxic multinodular goitre and active Graves' disease. Kiy Y; Rezkallah-Iwasso MT; Peraçoli MT; Mota NG Clin Endocrinol (Oxf); 1982 Jan; 16(1):11-7. PubMed ID: 6896172 [TBL] [Abstract][Full Text] [Related]
2. Humoral and cell-mediated immunity in large non-toxic multinodular goitre. Mota NG; Kiy Y; Rezkallah-Iwasso MT; Peraçoli MT Clin Endocrinol (Oxf); 1980 Aug; 13(2):173-80. PubMed ID: 7438471 [TBL] [Abstract][Full Text] [Related]
3. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre. Wallaschofski H; Kuwert T; Lohmann T Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319 [TBL] [Abstract][Full Text] [Related]
4. Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre? Brown RS; Jackson IM; Pohl SL; Reichlin S Lancet; 1978 Apr; 1(8070):904-6. PubMed ID: 76846 [TBL] [Abstract][Full Text] [Related]
5. The usefulness of conventional and echo colour Doppler sonography in the differential diagnosis of toxic multinodular goitres. Boi F; Loy M; Piga M; Serra A; Atzeni F; Mariotti S Eur J Endocrinol; 2000 Sep; 143(3):339-46. PubMed ID: 11022175 [TBL] [Abstract][Full Text] [Related]
6. Immunological characterization of mononuclear cells in thyroid gland and blood in Graves' disease, multinodular goiter and papillary carcinoma. Aanderud S; Matre R; Varhaug JE Int Arch Allergy Appl Immunol; 1982; 69(2):137-42. PubMed ID: 6896702 [TBL] [Abstract][Full Text] [Related]
7. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682 [TBL] [Abstract][Full Text] [Related]
8. Direct and quantitative measurement by immunoprecipitation assay of anti-thyrotrophin receptor antibodies in sera of patients with Graves' disease. de Bruin TW; van der Heide D; Querido A; Krol MC Clin Endocrinol (Oxf); 1984 Feb; 20(2):143-51. PubMed ID: 6325045 [TBL] [Abstract][Full Text] [Related]
9. Immunological features of sporadic multinodular goiter. Corrales JJ; Orfao A; Miralles JM; López-Berges MC; García LC; González M; Mories MT; San Miguel J Clin Investig; 1993 Jul; 71(7):552-8. PubMed ID: 8374249 [TBL] [Abstract][Full Text] [Related]
10. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism. Kraiem Z; Glaser B; Yigla M; Pauker J; Sadeh O; Sheinfeld M J Clin Endocrinol Metab; 1987 Oct; 65(4):659-64. PubMed ID: 2888784 [TBL] [Abstract][Full Text] [Related]
11. [Migration inhibition test with thyroid membrane antigen in Graves-Basedow disease and nodular goiter]. Jarzab J; Bachowska E; Jarzab B; Skrzypek J; Waler J Endokrynol Pol; 1991; 42(3):397-405. PubMed ID: 1364488 [TBL] [Abstract][Full Text] [Related]
13. Levels of soluble human leukocyte antigen class 1 are increased in Graves' disease and toxic multinodular goiter and correlate with the levels of triiodothyronine. Yaturu S; McDonald J Thyroid; 2002 Aug; 12(8):679-82. PubMed ID: 12225636 [TBL] [Abstract][Full Text] [Related]
14. The gamma delta T cell repertoire in Graves' disease and multinodular goitre. McIntosh RS; Tandon N; Pickerill AP; Davies R; Barnett D; Weetman AP Clin Exp Immunol; 1993 Dec; 94(3):473-7. PubMed ID: 8252809 [TBL] [Abstract][Full Text] [Related]
15. Graves' disease occurring after surgery of a multinodular goiter: a case report. Heinzel A; Müller HW; Poeppel TD; Engers R; Hautzel H Exp Clin Endocrinol Diabetes; 2009 Feb; 117(2):95-7. PubMed ID: 18563680 [TBL] [Abstract][Full Text] [Related]
16. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre. Chiovato L; Santini F; Vitti P; Bendinelli G; Pinchera A Clin Endocrinol (Oxf); 1994 Jun; 40(6):803-6. PubMed ID: 8033373 [TBL] [Abstract][Full Text] [Related]
17. [Cytofluorymetric evaluation of antigen regions of human thyroid peroxidase in patients with Graves' disease and non-toxic multinodular goiter using mouse monoclonal antibodies]. Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Peter A; Dadan J Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(1):19-26. PubMed ID: 15850534 [TBL] [Abstract][Full Text] [Related]
18. Thyroid epithelial cell proliferation in xenotransplanted human toxic nodular goitre is increased by Graves' IgG. Smeds S; Jörtsö E; Tegler L Acta Endocrinol (Copenh); 1991 Oct; 125(4):416-9. PubMed ID: 1957560 [TBL] [Abstract][Full Text] [Related]
19. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis. Wägar G; Mäkinen T; Lamberg BA; Gordin A; Apter L; Pekonen F Ann Clin Res; 1982 Apr; 14(2):83-9. PubMed ID: 6184007 [TBL] [Abstract][Full Text] [Related]
20. Goitre size and outcome of medical treatment of Graves' disease. Laurberg P; Buchholtz Hansen PE; Iversen E; Eskjaer Jensen S; Weeke J Acta Endocrinol (Copenh); 1986 Jan; 111(1):39-43. PubMed ID: 3753814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]